BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15473941)

  • 1. [A new applicator with regulatable air bag designed for intracavitary brachytherapy of nasopharyngeal carcinoma].
    Zhang N; Wei GY; Tan YC; Huang ZL; Li SE; Lu ZQ
    Ai Zheng; 2004 Oct; 23(10):1222-4. PubMed ID: 15473941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients].
    Cao X; Chen K; He Z
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavitary irradiation of nasopharyngeal carcinoma using Ir-192 in Foley's catheter.
    Pattaranutaporn P; Chansilpa Y; Panichevaluk A
    J Med Assoc Thai; 1996 Jan; 79(1):31-5. PubMed ID: 8867399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Individual silicon applicator for nasopharyngeal brachytherapy].
    Schick B; Weiss R; Niewald M; Schneider MH
    Laryngorhinootologie; 2004 Aug; 83(8):507-11. PubMed ID: 15316890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
    Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
    Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
    Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx.
    Levendag PC; Peters R; Meeuwis CA; Visch LL; Sipkema D; de Pan C; Schmitz PI
    Radiother Oncol; 1997 Oct; 45(1):95-8. PubMed ID: 9364638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective study on long-term efficacy of external plus intracavitary radiotherapy on stage I-II nasopharyngeal carcinoma].
    Cao XP; Lu TX; Ye WJ; Cui NJ
    Ai Zheng; 2007 Feb; 26(2):204-7. PubMed ID: 17298754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized conformal high-dose-rate brachytherapy boost for limited-volume nasopharyngeal cancer.
    Ng T; Richards GM; Emery RS; Ho G; Yung R; Cheng A; Berson AM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):754-61. PubMed ID: 15708254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: treatment techniques and results.
    Maalej M; Ben Ammar CN; Kochbati L; Frikha H; Hentati D; Gargouri W; Besbes M
    Cancer Radiother; 2007 May; 11(3):117-21. PubMed ID: 17293150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions.
    Wulf J; Popp K; Oppitz U; Baier K; Flentje M
    Strahlenther Onkol; 2004 Apr; 180(4):216-24. PubMed ID: 15057432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
    Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
    Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavitary radiation treatment of nasopharyngeal carcinoma by the high dose rate afterloading technique.
    Zhang YW; Liu TF; Fi CX
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):315-8. PubMed ID: 2921132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.
    Garrán C; Montesdeoca N; Martínez-Monge R
    Brachytherapy; 2008; 7(3):267-9. PubMed ID: 18635026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma.
    Hua YJ; Chen MY; Qian CN; Hong MH; Zhao C; Guo L; Guo X; Cao KJ
    Head Neck; 2009 Jun; 31(6):807-12. PubMed ID: 19340873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [60Co teletherapy plus afterloading intracavitary radiation in nasopharyngeal carcinoma--report on 22 patients].
    Zhang YW
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):52-4. PubMed ID: 3979253
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
    Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.